Pt. Telfer et al., CHRONIC HEPATITIS-C VIRUS-INFECTION IN HEMOPHILIC PATIENTS - CLINICAL-SIGNIFICANCE OF VIRAL GENOTYPE, Thrombosis and haemostasis, 74(5), 1995, pp. 1259-1264
We have undertaken a comprehensive study of hepatitis C virus (HCV) ge
notype and its clinical significance in haemophilic patients. 189 HCV
RNA positive patients were typed, using the Simmonds classification sc
heme, by restriction fragment length polymorphism (RFLP) in an amplifi
ed segment of the 5' non-coding region of the HCV genome. Type 1 was f
ound in 121 (64.0%), type 2 in 23 (12.2%), type 3 in 36 (19.0%), type
4 in 3 (1.6%), type 5 in 2 (1.1%) and mixed infection in 3 (1.6%). The
re were no type 6 infections and one patient (0.5%) could not be typed
. Genotype was not associated with diagnosis, age,or with HIV infectio
n. Type 1 was associated with higher serum HCV RNA levels, and with a
poor response to interferon. Progression to hepatic decompensation has
been seen less frequently in those with type 3 compared to type 1 inf
ection (p = 0.07). Three out of eleven patients studied over a longer
time course showed a change in genotype, the remainder were persistent
ly infected with HCV type 1. In conclusion, HCV genotype has clinical
relevance in the management of haemophilic patients. Those with type 1
are probably more likely to develop serious liver disease and since t
hey respond poorly to interferon-alpha, should be considered for new t
reatment strategies aimed at sustained clearance of HCV RNA.